SCIENTIFIC EVIDENCES ON THERAPEUTIC METHODS IN TREATMENT OF FOURNIER'S GANGRENE
Keywords:Fournier's Gangrene, Therapeutic, Prevalence.
Introduction: Fournier's Gangrene consists of multi-bacterial rapid progression infection, involving genital, abdominal, and perineal region, promoting affected tissue necrosis. Considered a public health problem, compromises the patient life quality, and has high mortality coefficients.
Objective: Analyzing in the literature the therapeutic measures in patients diagnosed with Fournier's Gangrene.
Methodology: Integrative review from productions picked up in LILACS, IBECS, MEDLINE, PUBMED, and CUMED databases in the period 2005 to 2015. Fournier's Gangrene, Prevalence and Therapy descriptors in English and Portuguese were used. The search amounted to 765 productions, of which 17 were included as a sample for this study.
Results: The analysis regarding the publications enabled the construction of two thematic categories: demographic, epidemiological and clinical aspects of patients diagnosed with Fournier's Gangrene and the therapeutic modalities in treating Fournier's Gangrene. It was observed that the disease is prevalent in males, elderly, and people with diabetes mellitus. The treatment is based on antibiotics, surgical debridement, and skin reconstruction for the affected areas.
Conclusion: The diagnosis, assessment and multidisciplinary early intervention are essential to ensure proper treatment and life maintenance.
Waugh MA. Alfred Fournier, 1832-1914. His influence on venereology. Br J Vener Dis. 1974 Jun; 50(3):232-236.
Pacios JCL, Merino JMS, FernÃ¡ndez MCP, Montero MB, Muntaner LP, Alonso JG. Gangrena de Fournier secundaria a cateterismo uretral. Arch Esp Urol. 2005 Mar; 58(2):167-170.
SroczyÅ„ski M, Sebastian M, Rudnicki J, Sebastian A, Agrawal AK. A complex approach to the treatment of Fournierâ€™s gangrene. Adv Clin Exp Med. 2013 Jan; 22(1):131-135.
Chan CC, Williams M. Fournier gangrene as a manifestation of undiagnosed metastatic perforated colorectal cancer. Int Surg. 2013 Jan; 98(1):43-48.
Vyas HG, Kumar A, Bhandari V, Kumar N, Jain A, Kumar R. Prospective evaluation of risk factors for mortality in patients of Fournier's gangrene: A single center experience. Indian J Urol. 2013 July; 29(3):161-165.
Mehl AA, Nogueira Filho DC, Mantovani LM, Grippa MM Berger R, Krauss D, et al. Management of Fournierâ€™s gangrene: experience of a university hospital of Curitiba. Rev Col Bras Cir. 2010 Nov; 37(6):435-441.
CandelÃ¡ria PAP, Klug WA, Capelhuchnik P, Fang CB. Analysis of mortality in Fournier's gangrene. Rev Bras Coloproct. 2009 Apr; 29(2):197-202.
Rocha ST, Filho JBC, Petry MS, Bernardi RM, Bueno GB, Warmling CZ. Initial experience hyperbaric therapy fournier syndrome in a referral hospital in southern Santa Catarina. ACM arq catarin med. 2012 Oct; 41(4):71-76.
Cavalini F, Moriera TM, Pelei NTR. The perception of the Fournier syndrome's patient. Rev Esc Enferm USP. 2002 June; 36(2):108-114.
Silveira RCCP, GalvÃ£o CMO. Nursing care and Hickmanâ€™s catheter: the search for evidence. Acta paul enferm. 2005 July; 18(3):276-284.
Mendes KDS, Silveira RCCP, GalvÃ£o CM. Integrative literature review: a research method to incorporate evidence in health care and nursing. Texto & contexto enferm. 2008 July; 17(4):758-764.
Anantha RV, Kasper KJ, Patterson KG, Zeppa JJ, Delport J, McCormick JK. Fournierâ€™s gangrene of the penis caused by Streptococcus dysgalactiae subspecies equisimilis: case report and incidence study in a tertiary-care hospital. BMC Infect Dis. 2013 Aug; 13:381-385.
Sorensen MD, Krieger JN, Rivara FP, Broghammer JA, Klein MB, Mack CD, et al. Fournierâ€™s gangrene: population based epidemiology and outcomes. J Urol. 2009 May; 181(5):2120-2126.
EskitaÅŸcÄ±oÄŸlu T, Ã–zyazgan Ä°, Coruh A, GÃ¼nay GK, AltÄ±parmak M, Yontar Y, DoÄŸan F. Experience of 80 cases with Fournierâ€™s gangrene and â€œtraumaâ€ as a trigger factor in the etiopathogenesis. Ulus Travma Acil Cerrahi Derg. 2014 July; 20(4):265-274.
Aridogan A, Izol V, Abat D, Karsli O, Bayazit Y, Satar N. Epidemiological characteristics of Fournierâ€™s gangrene: a report of 71 patients. Urol Int. 2012 Oct; 89(4):457-461.
Carvalho JP, Hazan A, Cavalcanti AG, Favorito LA. Relation between the area affected by Fournier's gangrene and the type of reconstructive surgery used: a study with 80 patients. International Braz J Urol. 2007 Jun; 33(4):510-514.
Omisanjo OA, Bioku M J, Ikuerowo S O, Sule G A, Esho J O. Clinical characteristics and outcome of management of Fournier's gangrene at the Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria. Ann Afr Med. 2014 Oct; 13(4):174-178.
Chinchillaa RM, Morejona EI, PietricicÃ¢a BN, Francob EP, Albasinib JLA, LÃ³peza BM. Fournier's gangrene. Descriptive analysis of 20 cases and literature review. Actas Urol Esp. 2009 Sept; 33(8): 873 â€“ 880.
Medina PJ, Tejido SA, Kehrmann RF, SantamarÃa FN, Ãlvarez BM, Galvis LO. Fournier Gangrene: evaluation of prognostic factors in 90 patients. Actas Urol Esp. 2008 Nov; 32(10):1024-1030.
SÃ¡mano VL, Pineda GI, Alcaraz EM, MartÃnez GM, Brambila ES, AlarcÃ³n, JP. FournierÂ´s gangrene. Experience of the CMN SXXI Hospital. Arch Esp Urol. 2007 June; 60(5):525-530.
Dornelas MT, Correa MPD, Barra FML, Correa LD, Silva EC, Dornelas GV, et al. Fournier's syndrome: a 10-year evaluation study. Rev Bras Cir PlÃ¡st. 2012 Oct; 27(4):600-604.
Janane A, Hajji F, Ismail TO, Chafiqui J, Ghadouane M, Ameur A, et al. Hyperbaric oxygen therapy adjunctive to surgical debridement in management of Fournier's gangrene: usefulness of a severity index score in predicting disease gravity and patient survival. Actas Urol Esp. 2011 June; 35(6):332-338.
Neto IJFC, Sia ON, Rolim AS, Souza RFL, WattÃ© HH, Robles L. Clinical outcomes of Fournierâ€™s gangrene from a tertiary hospital. J Coloproctol. 2012 Oct; 32(4):407-410.
Haidari M, Nazer MR, Ahmadinejad M, Almasi V, Khorramabadi MS, Pournia Y. Honey in the treatment of Fournierâ€™s gangrene as an adjuvant: a cross sectional study. J Pak Med Assoc. 2014 May; 64(5):571-573.
Tovar RJ, CÃ³rdoba L, Devesa JM. Prognostic factors in Fournier gangrene. Asian J Surg. 2012 Jan; 35(1):37-41.
Altarac S, KatuÅ¡in D, Crnica S, PapeÅ¡ D, RajkoviÄ‡ Z, Arslani N. Fournierâ€™s gangrene: etiology and outcome analysis of 41 patients. Urol Int. 2012 Mar; 88(3):289-293.
Ersoz F, Sari S, Arikan S, Altiok M, Bektas H, Adas G, et al. Factors affecting mortality in Fournierâ€™s gangrene: experience with fifty-two patients. Singapore Med J. 2012 Aug; 53(8):537-540.
Barreda TJ, Scheiding MM, FernÃ¡ndez CS, CamaÃ±a JMC, Aguilera, JR, Miranda, EF, et al. Fournier gangrene: a retrospective study of 41 cases. Cir Esp. 2010 Apr; 87(4):218-223.
Cardoso JB, FÃ©res O. Gangrena de Fournier. HC Medicina CARL. 2007 Oct; 40(4):493-9.
Aron S, Gamba MA. Wound Bed Preparation and a History of TIME. Rev Estima. 2009; 7(4):20-24.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under aÂ Creative Commons Attribution LicenseÂ that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeÂ The Effect of Open AccessÂ and Benefits of Publishing Open Access).